Assignee
CHENGDU CYNOGEN BIO PHARMACEUTICAL TECH CO LTD
CN·1 granted patent·1 pending application·0 citations·filing 2020–2021
Top patents by PatentIndex Score
2 records- 0147US2023416271A1Heteroarylquinazoline compounds as protein kinase inhibitorsCHENGDU CYNOGEN BIO PHARMACEUTICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 0241US12312355B21H-[1, 2, 3]triazolo[4, 5-h] quinazoline compounds acting as protein kinase inhibitorsCHENGDU CYNOGEN BIO PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted May 27, 2025·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when CHENGDU CYNOGEN BIO PHARMACEUTICAL TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →